Crossmark

Structural insight into PRMT5 inhibitors through amalgamating pharmacophore-based virtual screening, ADME toxicity, and binding energy studies to identify new inhibitors by molecular docking

Crossref DOI link: https://doi.org/10.1007/s11224-022-01918-y

Published Online: 2022-04-11

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bathula, Revanth

Lanka, Goverdhan

Chakravarty, Madhulika

Somadi, Gururaj

Sivan, Sree Kanth

Jain, Alok

Potlapally, Sarita Rajender https://orcid.org/0000-0002-6453-9705
Funding

Funding for this research was provided by:

Council of Scientific and Industrial Research, India (09/132 (0846)/2015-EMR-I (fellowship assistance))
License Information

Text and Data Mining valid from 2022-04-11

Version of Record valid from 2022-04-11
More Information

Article History

Received: 19 August 2021

Accepted: 10 March 2022

First Online: 11 April 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below